Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00402389 · ClinicalTrials.gov registry record · Phase 2
Use of Omega-3 Fatty Acids for Perinatal Depression
A Phase 2 study, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00402389 is a Phase 2 study that has completed, run by University of Arizona. The registered enrollment target is 50 participants.
The verdict
NCT00402389, a Phase 2 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of using omega-3 fatty acids to treat women with perinatal depression.
Interventions
- DRUG Placebo
- DRUG Omega-3 Fatty Acids (EPA plus DHA)
- BEHAVIORAL Supportive psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2004-06 |
| Est. Completion | 2006-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00402389
The ClinicalTrials.gov registry entry for NCT00402389 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00402389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00402389 about?
NCT00402389 is a clinical study titled "Use of Omega-3 Fatty Acids for Perinatal Depression". This study will evaluate the effectiveness of using omega-3 fatty acids to treat women with perinatal depression.
What is the current status of trial NCT00402389?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2004-06. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00402389?
The interventions under investigation include: Placebo (DRUG), Omega-3 Fatty Acids (EPA plus DHA) (DRUG), Supportive psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00402389?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.